Neurotóxic and neuroprotectors effects for the use of cannabis in neurodegenerative disease
Cannabis is a group of chemicals present in the Cannabis sativa plant, commonly known as marijuana. The main psychoactive cannabinoid and the most studied is tetrahydrocannabinol (THC). Nationally and globally, it is the most commonly used illegal drug. It is estimated that around 180 million people...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Online |
| Langue: | spa |
| Publié: |
REMUS - Revista Estudiantil de Medicina de la Universidad de Sonora
2019
|
| Accès en ligne: | https://ojs-remus.unison.mx/index.php/remus_unison/article/view/44 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
| Résumé: | Cannabis is a group of chemicals present in the Cannabis sativa plant, commonly known as marijuana. The main psychoactive cannabinoid and the most studied is tetrahydrocannabinol (THC). Nationally and globally, it is the most commonly used illegal drug. It is estimated that around 180 million people consume it, mainly young people, who represent the most vulnerable population. Its popularity is a result in part to its depressive effects of the nervous system, among which are relaxation, feeling of well-being and alterations in perception; in addition to the innumerable myths about its therapeutic applications, among which are relief of chronic pain, greater concentration, and recently, the neuroprotective effect of some cannabinoids and their role in the treatment of neurodegenerative diseases such as the Alzheimer’s disease, Multiple Sclerosis and Parkinson's disease; being this last circumstance the reason that justifies the realization of a bibliographic review about the truly beneficial and scientifically sustained effects, as well as the neurotoxic effects that could occur in the short and long term, so that both can be contrasted to reach a conclusion. |
|---|
